(492657), A. R., (4246147), M. M., (14153292), V. P. I., (1297770), R. K., (14153295), A. R., (154400), S. U., & (14153298), S. D. (2022). Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(492657), Afsheen Raza, Maysaloun Merhi (4246147), Varghese Philipose Inchakalody (14153292), Roopesh Krishnankutty (1297770), Allan Relecom (14153295), Shahab Uddin (154400), و Said Dermime (14153298). Unleashing the Immune Response to NY-ESO-1 Cancer Testis Antigen as a Potential Target for Cancer Immunotherapy. 2022.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(492657), Afsheen Raza, et al. Unleashing the Immune Response to NY-ESO-1 Cancer Testis Antigen as a Potential Target for Cancer Immunotherapy. 2022.